Bioanalysis Zone

Evolution of fit-for-purpose biomarker validations: an LBA perspective

0

Biomarker ligand-binding assays need to be validated for use on clinical studies in the drug development process. There is not one single guidance to cover all types of biomarker assays and their intended uses. Therefore,

To view restricted content, please:

LB_Q3-spotlight-view

Share:

Leave A Comment